Replies to post #1651 on Vascular Biogenics Ltd (VBLT)

[avtrdr]

They do have great expectations for returned value and expect good synergy with VB-111.

From NanoCarrier's 2nd Qtr Report (FY ending 3/31/18):
Through rapid commercialization of this product into a revolutionary drug in Japan, we expect to strengthen our
operating basis at an early stage. In addition, in the future, the agreement will generate synergies in R&D from the fusion of
the technologies of both companies and it will be possible to develop even more revolutionary new drugs... Furthermore, we are aiming at the development of a therapeutic drug using our micellar- nanoparticle formulation that targets tumor cells. By having a pipeline with two drugs with different mechanisms, our company will secure its position in the entire cancer field and aims to contribute to society.

[Jumpinjackas]

Yes, but if they are confident about their market. Imagine the BP inside US, you think there are discussions already? In short time we will see why they wanted the additional funds